Related Experiment Video
Updated: Jul 7, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Sandro K Cinti1, Tejal Gandhi, James Riddell
1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
Abstract:
Non-AIDS-defining cancers have recently gained more attention, and it appears that several of these cancers may be more common the the HAART era. By most accounts in the literature, the overall risk of non-AIDS-defining cancer in HIV-infected persons is 2 to 3 times that in the general population. In this article, we review the literature on 5 of the most common non-AIDS-defining cancers (Hodgkin disease, anal cancer, hepatocellular carcinoma, oral cancer, and lung cancer) in the pre- and post-HAART periods. It remains unclear whether earlier initiation (CD4+ cell count above 350/microL) of antiretroviral therapy may be beneficial in preventing non-AIDS-defining cancer. Further large-scale, randomized, prospective studies on this question are warranted.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

